TGIF1 promoted the growth and migration of cancer cells in nonsmall cell lung cancer

被引：28
|
作者：
Guo Xiang [1 ]
Yang Yi [1 ]
He Weiwei [1 ]
Wu Weiming [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Thorac Surg, Shanghai 200233, Peoples R China
来源：
TUMOR BIOLOGY | 2015年 / 36卷 / 12期
关键词：
Nonsmall cell lung cancer; TGIF1; Beta-catenin/TCF signaling; Cell growth; Migration; SIGNALING PATHWAY; CATENIN; ADENOCARCINOMA; STATISTICS; MUTATION; GENE;
D O I：
10.1007/s13277-015-3676-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Transforming growth factor beta-inducing factor 1 (TGIF1) was reported to be dysregulated in several types of cancer. However, its expression pattern and functions in nonsmall cell lung cancer (NSCLC) remained unknown. In the present study, the expression of TGIF1 was found to be elevated in the clinical NSCLC tissues. TGIF1 promoted the growth and migration of NSCLC cells, while knocking down the expression of TGIF1 inhibited the growth and migration of NSCLC cells. Moreover, downregulation of TGIF1 impaired the metastasis of NSCLC cells. In the study for the molecular mechanisms, it was found that TGIF1 positively regulated beta-catenin/TCF signaling. In summary, our study demonstrated the oncogenic role of TGIF1 in NSCLC, and TGIF1 might be a therapeutic target for NSCLC.
引用
收藏
页码：9303 / 9310
页数：8
相关论文
共 50 条
  • [21] Troxacitabine prodrugs for nonsmall cell lung cancer
    Chu, Chung K.
    Radi, M.
    Adema, A. D.
    Hoebe, E. K.
    Alexander, L. M. M.
    Peters, G. J.
    CANCER RESEARCH, 2006, 66 (08)
  • [22] Modern therapies of nonsmall cell lung cancer
    Andrzej Jachowski
    Mikołaj Marcinkowski
    Jakub Szydłowski
    Oskar Grabarczyk
    Zuzanna Nogaj
    Łaz Marcin
    Andrzej Pławski
    Paweł Piotr Jagodziński
    Bartosz Kazimierz Słowikowski
    Journal of Applied Genetics, 2023, 64 : 695 - 711
  • [23] ALK Inhibitors in Nonsmall Cell Lung Cancer
    Garg, Nitish
    Kothari, Rushabh
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (01) : 67 - 70
  • [24] DNA Methylation and Nonsmall Cell Lung Cancer
    Lu, Fang
    Zhang, Hong-Tao
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2011, 294 (11): : 1787 - 1795
  • [25] THERAPY OF NONSMALL CELL LUNG-CANCER
    KLASTERSKY, J
    LUNG CANCER, 1995, 12 : S133 - S145
  • [26] STAGING NONSMALL CELL LUNG-CANCER
    ARMSTRONG, P
    VINCENT, JM
    CLINICAL RADIOLOGY, 1993, 48 (01) : 1 - 10
  • [27] Stereotactic radiotherapy for nonsmall cell lung cancer
    Ball, David
    CURRENT OPINION IN PULMONARY MEDICINE, 2008, 14 (04) : 297 - 302
  • [28] Antiangiogenic therapy in nonsmall cell lung cancer
    Gutierrez, Martin
    Giaccone, Giuseppe
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (02) : 176 - 182
  • [29] Biological therapies in nonsmall cell lung cancer
    Zugazagoitia, Jon
    Molina-Pinelo, Sonia
    Lopez-Rios, Fernando
    Paz-Ares, Luis
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (03)
  • [30] Modern therapies of nonsmall cell lung cancer
    Jachowski, Andrzej
    Marcinkowski, Mikolaj
    Szydlowski, Jakub
    Grabarczyk, Oskar
    Nogaj, Zuzanna
    Marcin, Laz
    Plawski, Andrzej
    Jagodzinski, Pawel Piotr
    Slowikowski, Bartosz Kazimierz
    JOURNAL OF APPLIED GENETICS, 2023, 64 (04) : 695 - 711
12345